Tracing pharmaceuticals in South Asia: regulation, distribution and consumption

Lead Research Organisation: University of Edinburgh
Department Name: Sch of Social and Political Science

Abstract

Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.

Publications

10 25 50
 
Description Our research produced new insights into how excessive antibiotic prescribing in South Asia resulted from the fear of harm to reputations if antibiotics were not prescribed; clinical uncertainty, and the delay, absence or cost of taking diagnostic options led to rapid clinical diagnoses followed by prescriptions, often within a few minutes. Pharmaceutical companies encouraged such an approach by offering incentives for high levels of prescriptions. Practitioners unqualified in 'Western' medicine often did not know the appropriate treatment regimes - but in many cases, nor do those with an MB BS. At the household level, antibiotics may be stored, shared with others, purchased without prescriptions or medical advice, and taken in sub-therapeutic doses: prescriptions 'float' beyond the person to whom they were first issued. There is a possible role of sub-standard, counterfeit and fake/falsified products (but these are unknown and much-exaggerated in scale with respect to South Asia)
Exploitation Route It was taken forward in a further project funded by EU FP7 programme: Accessing Medicines in Africa and South Asia (AMASA) Grant agreement ID: 242262.
Sectors Healthcare

 
Description Discussed in debates over the appropriate use of medicines, especially of oxytocin or misoprostol in childbirth, to reduce post-partum haemorrhage; and in debates over responses to the rise of multi-drug resistant tuberculosis.
First Year Of Impact 2010
Sector Healthcare
Impact Types Policy & public services